非小细胞肺癌分子生物标志物时代的细胞学涂片:以少做多
本文综述了分子细胞病理学在非小细胞肺癌(NSCLC)分子检测中的进展与适用性。细胞学样本尤其是直接涂片可用于分子检测,快速现场评估可提高样本 adequacy,二代测序可在极微量 DNA 上完成突变分析,FISH 可检测 ALK 和 ROS1 重排,PD-L1 表达评估正在发展中。
要点
- 细胞学样本(尤其直接涂片)适用于 NSCLC 分子检测,可避免组织活检取材困难。
- 细胞病理医师快速现场评估可提高样本充足性并优化分子检测管理。
- 细胞学 FISH 可评估整个肿瘤细胞核,避免组织切片截断伪影导致的信号丢失。
核心结论
- 分子检测可在细胞学标本尤其是直接涂片上完成,分子细胞病理学在 NSCLC 中具有重要应用价值。
研究设计与样本
- 数据来源包括同行评议文献和作者个人经验。
主要发现
- 高达70%的NSCLC患者在晚期诊断,组织活检常无法进行。
- 快速现场评估由细胞病理医师进行,提高了细胞学样本用于分子检测的充足性和管理。
- 二代测序可利用极少量DNA对细胞学样本进行NSCLC突变谱分析。
- 细胞学标本FISH检测用于检测NSCLC中的ALK和ROS1重排,相比组织学具有独特优势。
- 细胞学标本可评估整个肿瘤细胞核,避免截断伪影导致的信号丢失;PD-L1蛋白表达评估正在发展中。
关键数值与推荐
- 细胞学标本FISH检测用于检测NSCLC中的ALK和ROS1重排。
- 亚硫酸氢盐转化和DNA微滴数字PCR方案已针对细胞学涂片优化,用于研究NSCLC相关基因的异常DNA甲基化。
临床怎么用
- 对晚期NSCLC无法获取组织活检的患者,可优先使用细胞学样本(尤其直接涂片)进行分子检测。
- 推荐细胞病理医师进行快速现场评估以提高细胞学样本用于分子检测的充足性。
- 细胞学FISH可用于检测ALK和ROS1重排,并避免组织切片截断伪影。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: - The rapid advances in targeted therapies in non-small cell lung cancer (NSCLC) make the optimization and implementation of cytology specimens for molecular testing a priority. Up to 70% of patients with NSCLC are diagnosed at advanced stages and tissue biopsies often cannot be taken. Although cytology samples provide high-quality material for molecular testing, molecular cytopathology is not yet well known or widely used. OBJECTIVE: - To report the many advances in molecular cytopathology and the suitability and utility of cytology samples in molecular and genetic testing of NSCLC. DATA SOURCES: - Data sources comprised published peer-reviewed literature and personal experience of the authors. CONCLUSIONS: - Molecular testing can be performed on cytologic specimens, especially on direct smears. Rapid on-site evaluation by cytopathologists has improved the adequacy and the management of cytology samples for molecular testing. Mutational profiling of NSCLC using next-generation sequencing can be performed on cytology samples from very small amounts of DNA. Fluorescence in situ hybridization assays on cytology specimens, including stained direct smear, offer some distinct advantages over their histologic counterpart, and are used to detect ALK and ROS1 rearrangements in NSCLC. Cytology specimens allow assessment of the entire tumor cell nucleus, avoiding signal loss from truncation artifacts. The use of cytology samples for assessing programmed death ligand-1 protein expression is currently being developed. Protocols for bisulfite conversion and DNA droplet digital polymerase chain reaction assays have been optimized for cytology smear to investigate aberrant DNA methylation of several NSCLC-related genes.
引用
- Lozano MD, Echeveste JI, Abengozar M, et al. Cytology Smears in the Era of Molecular Biomarkers in Non-Small Cell Lung Cancer: Doing More With Less. Arch Pathol Lab Med. 2018. PMID: 29494220. doi:10.5858/arpa.2017-0208-RA
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。